1.42
price up icon2.16%   0.03
after-market After Hours: 1.41 -0.01 -0.70%
loading

Lucid Diagnostics Inc Stock (LUCD) Latest News

pulisher
03:52 AM

Lucid Diagnostics Restores Nasdaq Listing Compliance - Nasdaq

03:52 AM
pulisher
09:59 AM

Lucid Diagnostics regains compliance with Nasdaq listing requirement - MSN

09:59 AM
pulisher
09:13 AM

Lucid Diagnostics meets Nasdaq minimum bid price rule By Investing.com - Investing.com South Africa

09:13 AM
pulisher
09:03 AM

Lucid Diagnostics meets Nasdaq minimum bid price rule - Investing.com

09:03 AM
pulisher
08:31 AM

Lucid Diagnostics Averts Delisting Risk: What This Nasdaq Compliance Means for Investors - StockTitan

08:31 AM
pulisher
Feb 21, 2025

Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health -February 20, 2025 at 08:31 am EST - Marketscreener.com

Feb 21, 2025
pulisher
Feb 20, 2025

Lucid Diagnostics secures concierge medicine contract By Investing.com - Investing.com Nigeria

Feb 20, 2025
pulisher
Feb 20, 2025

LUCDLucid Diagnostics Inc. Latest Stock News & Market Updates - StockTitan

Feb 20, 2025
pulisher
Feb 20, 2025

Lucid Diagnostics secures concierge medicine contract - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Can Lucid's New Concierge Medicine Deal Transform Its Revenue Model? - StockTitan

Feb 20, 2025
pulisher
Feb 19, 2025

PAVmed regains compliance with Nasdaq Capital Market’s CLS - Medical Buyer

Feb 19, 2025
pulisher
Feb 18, 2025

PAVMPavmed Latest Stock News & Market Updates - StockTitan

Feb 18, 2025
pulisher
Feb 18, 2025

Innovative Tech Company Surges Forward: PAVmed Triumphs in Nasdaq Compliance - Smartphone Magazine

Feb 18, 2025
pulisher
Feb 18, 2025

Navigating the High Seas of Market Compliance: PAVmed’s Resilient Return - Mi Valle

Feb 18, 2025
pulisher
Feb 18, 2025

PAVmed Triumphs on Nasdaq: A Medical Tech Comeback Story - Jomfruland.net

Feb 18, 2025
pulisher
Feb 18, 2025

Critical Victory: PAVmed's Strategic Moves Save Nasdaq StatusFull Details Inside - StockTitan

Feb 18, 2025
pulisher
Feb 17, 2025

SI-BONE (NASDAQ:SIBN) vs. Lucid Diagnostics (NASDAQ:LUCD) Head to Head Survey - Defense World

Feb 17, 2025
pulisher
Feb 16, 2025

Lucid Diagnostics stock hits 52-week high at $1.5 amid growth optimism - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Lucid Diagnostics (NASDAQ:LUCD) vs. Insulet (NASDAQ:PODD) Head-To-Head Review - Defense World

Feb 16, 2025
pulisher
Feb 14, 2025

Lucid Diagnostics stock hits 52-week high at $1.5 amid growth optimism By Investing.com - Investing.com South Africa

Feb 14, 2025
pulisher
Feb 10, 2025

Lucid Diagnostics Inc (LUCD) receives a Buy rating from Ascendiant Capital Markets - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Behind Lucid Diagnostics Inc’s 52-Week Range: Uncovering Opportunities for Investors - The InvestChronicle

Feb 10, 2025
pulisher
Feb 10, 2025

Lucid Diagnostics Inc (LUCD) Shares Rise Despite Market Challenges - The News Heater

Feb 10, 2025
pulisher
Feb 09, 2025

Sargent Investment Group LLC Purchases Shares of 541,500 Lucid Diagnostics Inc. (NASDAQ:LUCD) - MarketBeat

Feb 09, 2025
pulisher
Feb 07, 2025

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science and Diagnostic Tools Conference - Marketscreener.com

Feb 07, 2025
pulisher
Feb 06, 2025

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Victoria Advocate

Feb 06, 2025
pulisher
Feb 06, 2025

Cancer Prevention Leader Lucid Diagnostics Takes Center Stage at Elite BTIG Healthcare Summit - StockTitan

Feb 06, 2025
pulisher
Jan 26, 2025

Lucid Diagnostics Provides Business Update and Second Quarter 20 - GuruFocus.com

Jan 26, 2025
pulisher
Jan 21, 2025

Lucid Diagnostics (NASDAQ:LUCD) Stock Price Down 0.5%What's Next? - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

Lucid Diagnostics (NASDAQ:LUCD) Stock Price Down 0.5% – Here’s What Happened - Defense World

Jan 21, 2025
pulisher
Jan 13, 2025

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume - PR Newswire

Jan 13, 2025
pulisher
Jan 13, 2025

Lucid Diagnostics Achieves Record-Breaking Quarter with 84% Surge in EsoGuard DNA Test Volume - StockTitan

Jan 13, 2025
pulisher
Jan 08, 2025

Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit - Kilgore News Herald

Jan 08, 2025
pulisher
Dec 26, 2024

Lucid Inks New Partnership With VITALExam: Stock to Gain? - MSN

Dec 26, 2024
pulisher
Dec 25, 2024

Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophag - GuruFocus.com

Dec 25, 2024
pulisher
Dec 23, 2024

Lucid Gains Extension of Compliance by NASDAQ - Baystreet.ca

Dec 23, 2024
pulisher
Dec 23, 2024

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - Quantisnow

Dec 23, 2024
pulisher
Dec 23, 2024

Lucid Diagnostics Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Defense World

Dec 23, 2024
pulisher
Dec 23, 2024

Lucid Diagnostics Gets Nasdaq Extension to Meet $1 Listing Requirement Through June 2025 - StockTitan

Dec 23, 2024
pulisher
Dec 20, 2024

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - The Eastern Progress Online

Dec 20, 2024
pulisher
Dec 19, 2024

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters - PR Newswire

Dec 19, 2024
pulisher
Dec 19, 2024

Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test - The Eastern Progress Online

Dec 19, 2024
pulisher
Dec 15, 2024

Lucid Diagnostics' SWOT analysis: stock faces challenges amid market potential - Investing.com

Dec 15, 2024
pulisher
Dec 11, 2024

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication - Morningstar

Dec 11, 2024
pulisher
Dec 11, 2024

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication (PR Newswire) - Aktiellt

Dec 11, 2024
pulisher
Dec 10, 2024

Lucid Diagnostics (NASDAQ:LUCD) Price Target Lowered to $7.00 at Ascendiant Capital Markets - Defense World

Dec 10, 2024
pulisher
Dec 09, 2024

Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Dec 09, 2024
pulisher
Dec 07, 2024

Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health - The Eastern Progress Online

Dec 07, 2024
pulisher
Dec 07, 2024

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones - The Eastern Progress Online

Dec 07, 2024
pulisher
Dec 07, 2024

PAVmed Provides Business Update and Third Quarter 2024 Financial Results - The Eastern Progress Online

Dec 07, 2024
pulisher
Dec 03, 2024

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones – Company AnnouncementFT.com - Financial Times

Dec 03, 2024
pulisher
Nov 30, 2024

Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Down 30.6% in November - MarketBeat

Nov 30, 2024
medical_devices ZBH
$107.35
price up icon 1.29%
medical_devices STE
$223.79
price up icon 0.05%
medical_devices PHG
$26.73
price up icon 2.89%
$88.32
price down icon 2.68%
$90.81
price up icon 0.26%
medical_devices EW
$71.45
price down icon 1.80%
Cap:     |  Volume (24h):